US$ 26.29
novo nordisk is cutting prices on its popular glp-1 drugs. to Cut U.S. List for Ozempic, Wegovy by Up to 50% Novo Nordisk to slash Ozempic
Description
GLP-1 agonists may exert a centrally mediated effect to reduce addictive behavior at least partly via dopamine modulation
10.4103/NRR.NRR-D-24-00001 60 SteinJ

Buhrmann, C., Shayan, P., Brockmueller, A., & Shakibaei, M

JAMA 2019;321:146680.PubMedPMC 24
[Google Scholar] 32.Harris E Poll: Roughly 12% of US Adults Have Used a GLP-1 Drug, Even If Unaffordable
Clinical trial data showing comparable percentage body weight reduction is the most direct measure of how close an alternative comes to tirzepatide performance
